COVID-19 IgG ANTIBODY TEST

Serology Test for
SARS-CoV-2 Antibodies

JDP, working in conjunction with the largest labs in the U.S., is proud to offer a Serology Test for SARS-CoV-2 Antibodies. This test investigates whether an individual has likely been exposed to the virus in the past and has developed antibodies.

Why

What is the purpose of
an antibody test?

The Serology Test for SARS-CoV-2 Antibodies. The test investigates whether an individual has been exposed to the virus in the past and has developed antibodies. The full benefits of testing are evolving rapidly.

  • Inform those who have had contact with the virus
  • Assess if an untested individual has had COVID-19 following symptoms that suggest COVID-19
  • Help assess those who suffer COVID-19 symptoms but test negative for SARS-CoV-2 NAA and negative for other respiratory pathogens.
Who

Who should be tested for
IgG antibodies?

Serology testing should be used for patients who were diagnosed with COVID-19 or had COVID-19 symptoms, and who have recovered. It may also be used by individuals who believe they might have had COVID-19 in the past and want confirmation. Serology testing is not intended as a diagnostic test for patients who are exhibiting COVID-19 symptoms.

How

Getting a test

1
1. Create an Account

Your personal account is private
and secure.

2
2. Order a Test

You will be asked to confirm your personal identity, and sign disclosures before purchasing a test.

3
3. Bring Order Form to Lab

Lab locator will find the nearest LabCorp to your zip code. Bring your order form with you and you will be tested.

Results

Results available in 2-4 days

JDP will send an email when results are ready. After authenticating
your identity through the secure link, you will be able to review your results.

FAQ

Frequenly Asked Questions

Q: What is the current testing availability of the Serology Test for SARS-CoV-2 Antibodies (IgG)?

A: Testing is currently available on a broad basis through JDP and their national lab partners.

Q: What does a positive or negative result mean?

A: A positive serologic result indicates that an individual has likely produced an immune response to the SARS-CoV-2 virus. A negative serologic result suggests that an individual has not developed detectable antibodies at the time of testing.

While contingent on a variety of factors, a negative result could be due to testing too early in the course of infection, the absence of exposure to the virus, or the lack of adequate immune response, which can be due to the conditions or treatments that suppress immune function.

Confirmation of infection with SARS-CoV-2 must be made through a combination of clinical evaluation and other applicable tests.

Decisions about ongoing monitoring, treatment or return to normal activities for patients being treated for suspected infection with SARS-CoV-2 should also be made in accordance with guidance from public health authorities.

Q: Does a positive result (patient has likely been exposed to the SARS-CoV-2 virus) mean I will not contract COVID-19?

A: Serology testing is not intended as a primary diagnostic test for COVID-19 and should not be used as the sole basis for a diagnosis nor assurance of immunity. The serology testing provides evidence that a patient has likely been exposed to the SARS-CoV-2 virus. Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.

Q: Does a positive result (patient has likely been exposed to the SARS-CoV-2 virus) mean I can resume my normal daily activities and routines?

A: Serology testing is not intended as a primary diagnostic test for COVID-19 and should not be used as the sole basis for a diagnosis nor assurance of immunity. The serology testing provides evidence that a patient has likely been exposed to the SARS-CoV-2 virus. Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E. Decisions about ongoing monitoring or return to normal activities should also be made in accordance with guidance from public health authorities.

Coming soon

Virtual Verified Identity Documentation (VVID)

VVID is JDP’s blockchain-secured ID card that puts your biometrically-coded identity, affiliated credentials, antibody status, and more at your fingertips. VVID is portable, shareable and you control who receives your information.

Get Test for Employers
& Organizations

Pricing to be released in the coming days

Get testing for employees, contractors, volunteers and other affiliated individuals.

Get Antibody Testing for a Organization

Order Tests for Yourself

coming soon

Legal Disclaimer: Serology testing is not intended as a primary diagnostic test for COVID-19 and should not be used as the sole basis for a diagnosis nor assurance of immunity. The serology testing provides evidence that a patient has likely been exposed to the SARS-CoV-2 virus. Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E. These tests have not been reviewed by the FDA, but are being offered by JDP’s participating national labs in accordance with the public health emergency guidance issued by the FDA on March 16, 2020. The IgG serologic assay is qualitative and reported as positive, negative, or equivocal. The test does not provide an antibody titer (i.e., quantitative assessment of the amount of antibodies present). SARS-CoV-2 Antibody IgG is not offered as a panel or profile.

Testing for organizations

Please contact us

Due to overwhelming demand, please contact us directly
to set up an account for organization-wide testing.

Or let us contact you

We'll get back to you in 1-2 business days.

Thank you!

Thank you for your submission.

A team member will be contacting you soon. Close